New Zealand markets open in 6 hours 25 minutes

Intercept Pharmaceuticals, Inc. (ICPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.82+0.06 (+0.32%)
As of 09:34AM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
379,842
363,468
312,690
252,002
Cost of revenue
3,285
3,100
5,322
4,212
Gross profit
376,557
360,368
307,368
247,790
Operating expenses
Research development
189,034
185,272
191,485
242,799
Selling general and administrative
221,613
230,855
332,493
317,418
Total operating expenses
410,647
416,127
523,978
560,217
Operating income or loss
-34,090
-55,759
-216,610
-312,427
Interest expense
31,099
51,875
48,054
41,144
Total other income/expenses net
-89,480
18,752
-10,216
8,890
Income before tax
-157,465
-91,426
-274,880
-344,681
Income from continuing operations
-157,465
-91,426
-274,880
-344,681
Net income
206,361
-91,426
-274,880
-344,681
Net income available to common shareholders
206,361
-91,426
-274,880
-344,681
Basic EPS
-
-2.87
-8.34
-10.89
Diluted EPS
-
-2.87
-8.34
-10.89
Basic average shares
-
31,894
32,970
31,654
Diluted average shares
-
31,894
32,970
31,654
EBITDA
-
-36,573
-223,708
-299,874